JPMorgan Chase & Co’s Contineum Therapeutics CTNM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.4K | Sell |
1,108
-4,059
| -79% | -$16.1K | ﹤0.01% | 5552 |
|
|
2025
Q1 | $36.1K | Sell |
5,167
-23,259
| -82% | -$162K | ﹤0.01% | 5124 |
|
|
2024
Q4 | $416K | Buy |
28,426
+25,934
| +1,041% | +$380K | ﹤0.01% | 4233 |
|
|
2024
Q3 | $47.7K | Sell |
2,492
-466
| -16% | -$8.92K | ﹤0.01% | 4999 |
|
|
2024
Q2 | $52.1K | Buy |
+2,958
| New | +$52.1K | ﹤0.01% | 4887 |
|